Circulating Tumor Cells in Breast Cancer

Area of Science:

• Oncology
• Cancer Biology
• Molecular Diagnostics

Background:

• Breast cancer mortality has decreased due to early detection and improved treatments.
• A significant number of patients with non-metastatic breast cancer experience relapse.
• Dissemination of circulating tumor cells (CTCs) in early stages may cause micrometastases and treatment failure.

Purpose of the Study:

• To review the clinical significance of CTCs in metastatic and non-metastatic breast cancer.
• To discuss the prognostic value of CTCs detected by the CellSearch® System.
• To explore ongoing research on CTC phenotypes for personalized breast cancer treatment.

Main Methods:

• Review of clinical studies on circulating tumor cells (CTCs).
• Analysis of data from the FDA-approved CellSearch® System for CTC detection.
• Evaluation of current research on CTC phenotypes and their role in treatment.

Main Results:

• Circulating tumor cells (CTCs) are associated with poorer outcomes in breast cancer patients.
• Current data is insufficient to guide treatment decisions based on CTC levels.
• Ongoing studies aim to assess CTC phenotypes for personalized treatment strategies.

Conclusions:

• CTCs may play a crucial role in early breast cancer progression and relapse.
• Further research is needed to establish CTCs as reliable biomarkers for treatment guidance.
• Investigating CTC phenotypes holds promise for developing personalized breast cancer therapies.